Skip to main
  1. Stocks
  2. Evotec SE
  3. Forecast
EVO

Evotec SE (EVO) Stock Forecast & Price Target

Evotec SE (EVO) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Evotec is supported by a clear sequential recovery in D&PD, with 3Q26 revenue of €164.9M up 14.9% QoQ and 9M26 revenue of €465.0M, while D&PD base-business orders rose 24% YoY and are now converting into revenue, especially in Discovery and Cyprotex. Cost actions are also strengthening the investment case, as the 3Q26 adjusted EBITDA loss narrowed to €1.6M from €15.0M a year earlier, gross margin expanded to 12.0%, and more than €15M of annualized savings had already been delivered by end-September toward the €15–22.5M FY26 target. Longer term, the approximately €1B revenue ambition for 2030 is backed by a diversified mix across D&PD, strategic partnerships, and JEB, while cash and cash equivalents of €299.0M and total liquidity of €400.9M provide a solid balance-sheet cushion.

Bears say

Evotec is facing a weakened fundamental outlook after cutting FY2026 revenue guidance to €570M-€610M from €700M-€780M, while adjusted EBITDA shifted from €0M to +€40M to a loss of €70M to €105M, signaling a sharper earnings deterioration than expected. The company’s lower outlook is driven by delayed milestone timing across partnerships, slower-than-expected conversion of new strategic deals in D&PD, and weaker sales-to-revenue conversion, all of which undermine visibility and leave its high fixed-cost base exposed to margin compression. Although liquidity improved to €465.6M as of June 30, 2026 and net cash was about €35M at the end of 2Q26, preliminary 2Q26 revenue of €143.5M still fell short of consensus, reinforcing the negative view on execution and near-term growth.

Evotec SE (EVO) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Evotec SE and is not a guaranteed prediction by Public.com or investment advice.

Evotec SE (EVO) Analyst Forecast & Price Prediction

Get the latest Evotec SE (EVO) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Evotec SE (EVO)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Evotec SE (EVO) Forecast

Analysts have given Evotec SE (EVO) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Evotec SE (EVO) has a Strong Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Evotec SE (EVO)


Evotec SE (EVO) Analyst Forecast & Price Prediction

Get the latest Evotec SE (EVO) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Evotec SE (EVO)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover EVO stock data and trends